The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes

Abstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In...

Full description

Bibliographic Details
Main Authors: Fatemeh Haidari, Mehrnoosh Zakerkish, Fatemeh Borazjani, Kambiz Ahmadi Angali, Golnaz Amoochi Foroushani
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-020-04401-3
id doaj-0a5d47a2109c431e9cfa6ca8543f6c77
record_format Article
spelling doaj-0a5d47a2109c431e9cfa6ca8543f6c772020-11-25T02:46:59ZengBMCTrials1745-62152020-06-0121111110.1186/s13063-020-04401-3The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetesFatemeh Haidari0Mehrnoosh Zakerkish1Fatemeh Borazjani2Kambiz Ahmadi Angali3Golnaz Amoochi Foroushani4Department of Nutrition, Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical SciencesHealth Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical SciencesDepartment of Nutrition, Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical SciencesDepartment of Biostatistic, School of Health, Ahvaz Jundishapur University of Medical SciencesHealth Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical SciencesAbstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In this study, 42 patients with type 2 diabetes were randomly allocated to intervention and control groups and received either 3 g/day dill powder or placebo (3 capsules/day, 1 g each). Fasting blood sugar, insulin, homeostatic model assessment of insulin resistance, lipid profile, high-sensitivity C-reactive protein, total antioxidant capacity, malondialdehyde and gastrointestinal symptoms were measured in all of the subjects at baseline and postintervention. Results The dill powder supplementation significantly decreased the mean serum levels of insulin, homeostatic model assessment of insulin resistance, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde in the intervention group in comparison with the baseline measurements (P < 0.05). Furthermore, the mean serum levels of high-density lipoprotein and total antioxidant capacity were significantly increased in the intervention group in comparison with the baseline measurement (P < 0.05). Colonic motility disorder was the only gastrointestinal symptom whose frequency was significantly reduced by supplementation (P = 0.01). The mean changes in insulin, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde were significantly lower in the intervention group than in the control group (P < 0.05). In addition, the mean changes in high-density lipoprotein were significantly higher in the intervention group than in the control group (P < 0.05). Conclusion Dill powder supplementation can be effective in controlling the glycemic, lipid, stress oxidative and gastrointestinal symptoms in patients with type 2 diabetes. Trial registration Iran Clinical Trials Registry: IRCT20120704010181N12 . Registered on 12 May 2018.http://link.springer.com/article/10.1186/s13063-020-04401-3Type 2 diabetesDill powderGlycemic controlLipid profileStress oxidative status
collection DOAJ
language English
format Article
sources DOAJ
author Fatemeh Haidari
Mehrnoosh Zakerkish
Fatemeh Borazjani
Kambiz Ahmadi Angali
Golnaz Amoochi Foroushani
spellingShingle Fatemeh Haidari
Mehrnoosh Zakerkish
Fatemeh Borazjani
Kambiz Ahmadi Angali
Golnaz Amoochi Foroushani
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
Trials
Type 2 diabetes
Dill powder
Glycemic control
Lipid profile
Stress oxidative status
author_facet Fatemeh Haidari
Mehrnoosh Zakerkish
Fatemeh Borazjani
Kambiz Ahmadi Angali
Golnaz Amoochi Foroushani
author_sort Fatemeh Haidari
title The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
title_short The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
title_full The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
title_fullStr The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
title_full_unstemmed The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
title_sort effects of anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
publisher BMC
series Trials
issn 1745-6215
publishDate 2020-06-01
description Abstract Background The objective of this study was to investigate the effects of Anethum graveolens (dill) powder supplementation on glycemic control, lipid profile, some antioxidants and inflammatory markers, and gastrointestinal symptoms in patients with type 2 diabetes. Materials and methods In this study, 42 patients with type 2 diabetes were randomly allocated to intervention and control groups and received either 3 g/day dill powder or placebo (3 capsules/day, 1 g each). Fasting blood sugar, insulin, homeostatic model assessment of insulin resistance, lipid profile, high-sensitivity C-reactive protein, total antioxidant capacity, malondialdehyde and gastrointestinal symptoms were measured in all of the subjects at baseline and postintervention. Results The dill powder supplementation significantly decreased the mean serum levels of insulin, homeostatic model assessment of insulin resistance, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde in the intervention group in comparison with the baseline measurements (P < 0.05). Furthermore, the mean serum levels of high-density lipoprotein and total antioxidant capacity were significantly increased in the intervention group in comparison with the baseline measurement (P < 0.05). Colonic motility disorder was the only gastrointestinal symptom whose frequency was significantly reduced by supplementation (P = 0.01). The mean changes in insulin, low-density lipoprotein cholesterol, total cholesterol and malondialdehyde were significantly lower in the intervention group than in the control group (P < 0.05). In addition, the mean changes in high-density lipoprotein were significantly higher in the intervention group than in the control group (P < 0.05). Conclusion Dill powder supplementation can be effective in controlling the glycemic, lipid, stress oxidative and gastrointestinal symptoms in patients with type 2 diabetes. Trial registration Iran Clinical Trials Registry: IRCT20120704010181N12 . Registered on 12 May 2018.
topic Type 2 diabetes
Dill powder
Glycemic control
Lipid profile
Stress oxidative status
url http://link.springer.com/article/10.1186/s13063-020-04401-3
work_keys_str_mv AT fatemehhaidari theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT mehrnooshzakerkish theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT fatemehborazjani theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT kambizahmadiangali theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT golnazamoochiforoushani theeffectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT fatemehhaidari effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT mehrnooshzakerkish effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT fatemehborazjani effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT kambizahmadiangali effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
AT golnazamoochiforoushani effectsofanethumgraveolensdillpowdersupplementationonclinicalandmetabolicstatusinpatientswithtype2diabetes
_version_ 1724755362896150528